India markets open in 1 hour 44 minutes

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.9000+0.0400 (+1.40%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5227.18M
Enterprise value 3145.73M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)15,145.23
Price/book (mrq)1.71
Enterprise value/revenue 39,715.29
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) -0.68
52-week change 39.43%
S&P500 52-week change 333.41%
52-week high 34.9600
52-week low 32.0100
50-day moving average 33.0450
200-day moving average 33.6956

Share statistics

Avg vol (3-month) 3436.41k
Avg vol (10-day) 3341.71k
Shares outstanding 578.34M
Implied shares outstanding 6N/A
Float 44.66M
% held by insiders 19.41%
% held by institutions 168.71%
Shares short (14-Jul-2021) 41.17M
Short ratio (14-Jul-2021) 42.52
Short % of float (14-Jul-2021) 4N/A
Short % of shares outstanding (14-Jul-2021) 41.50%
Shares short (prior month 14-Jun-2021) 41.52M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318-Aug-2019
Ex-dividend date 4N/A
Last split factor 2277:1000
Last split date 318-Aug-2019

Financial highlights

Fiscal year

Fiscal year ends 30-Dec-2020
Most-recent quarter (mrq)30-Mar-2021


Profit margin 0.00%
Operating margin (ttm)-263,920.00%

Management effectiveness

Return on assets (ttm)-18.32%
Return on equity (ttm)-28.78%

Income statement

Revenue (ttm)15k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)0.00%
Gross profit (ttm)15k
Net income avi to common (ttm)-37.38M
Diluted EPS (ttm)-0.5780
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)81.93M
Total cash per share (mrq)1.05
Total debt (mrq)484k
Total debt/equity (mrq)0.36
Current ratio (mrq)18.11
Book value per share (mrq)1.70

Cash flow statement

Operating cash flow (ttm)-35.54M
Levered free cash flow (ttm)-22.91M